Lower blood sugar and increased fat burning—without negatively affecting appetite or muscle mass. These are some of the most promising effects of a new potential drug treatment for people with type 2 diabetes and obesity, according to a study published in the journal Cell by researchers from Karolinska Institutet and Stockholm University.
This article was originally published on MedicalXpress.com